The neurobiology of impulse control disorders;Neurobiologia dos transtornos do controle do impulso

Revista Brasileira de Psiquiatria

Volumn 30, Issue SUPPL 1, 2008, Pages

  Williams, Wendol A ^a   Potenza, Marc N ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b West Haven Veteran's Administration Hospital

Author keywords

Dopamine; Norepinephrine; Opioids; Pathological gambling; Serotonin

Indexed keywords

BRAIN MONOAMINE; OPIATE RECEPTOR;

ADRENERGIC SYSTEM; ALLELE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DECISION MAKING; DOPAMINERGIC SYSTEM; GENETIC POLYMORPHISM; GENETICS; GENOMICS; HIGH RISK BEHAVIOR; HUMAN; IMPULSE CONTROL DISORDER; MALE; MEDLINE; NEUROBIOLOGY; NEUROIMAGING; NEUROMODULATION; NEUROTRANSMISSION; PATHOLOGICAL GAMBLING; PATHOLOGY; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; REVIEW; SEROTONINERGIC SYSTEM;

EID: 44849124090     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/s1516-44462008005000003     Document Type: Review

References (49)

1. . Potenza MN, Hollander E. Pathologic gambling and impulse control disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C, editors. Neuropsychopharmacology: the fifth generation of progress. Philadelphia, Pa: Lippincott Williams & Wilkins; 2002. p. 1425-43.
2. . Grant JE, Potenza MN. Impulse control disorders: clinical characteristics and pharmacological management. Ann Clin Psychiatry. 2004;16(1):27-34.
3. . Hollander E, Buchalter A, DeCaria C. Pathological gambling. Psychiatr Clin North Am. 2000;23(3):629-42.
4. . Potenza MN. Pathological gambling: clinical aspects and neurobiology. In: Soares J, Gershon S, editors. Handbook of Medical Psychiatry. New York: Marcel Dekker; 2002. p. 683-99.
5. . Potenza MN. The neurobiology of pathological gambling. Semin Clin Neuropsychiatry. 2001;6(3):217-26.
6. . Winstanley C, Theobald D, Dalley J, Cardinal R, Robbins T. Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice. Cereb Cortex. 2006;16(1):106-14.
7. . Moreno I, Saiz-Ruiz J, Lopez-Ibor J. Serotonin and gambling dependence. Hum Psychopharmacol. 1991;6(Suppl):9-12.
8. . DeCaria C, Begaz T, Hollander E. Serotonergic and noradrenergic function in pathological gambling. CNS Spectr. 1998;3(6):38-48.
9. . Blanco C, Orensanz-Munoz L, Blanco-Jerez C, Saiz-Ruiz J. Pathological gambling and platelet MAO activity: a psychological study. Am J Psychiatr. 1996;153(1):119-21.
10. Carrasco JL, Saiz-Ruiz J, Hollander E, Cesar J, Lopez-Ibor JJ Jr. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand. 1994;90(6):427-31.
11. Flament MF, Rapoport JL, Murphy DL, Berg CJ, Lake CR. Biochemical changes during clomipramine treatment of childhood obsessive-compulsive disorder. Arch Gen Psychiatry. 1987;44(3):219-25. Erratum: Arch Gen Psychiatry. 1987;44(6)548.
12. Hollander E, DeCaria CM, Mari E, Wong CM, Mosovich S, Grossman R, Begaz T. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry. 1998;155(12):1781-3.
13. Grant JE, Brewer JA, Potenza MN. The neurobiology of substance and behavioral addictions. CNS Spectr. 2006;11(12):924-30.
14. Pallanti S, Bernardi S, Quercioli L, Decaria C, Hollander E. Serotonin dysfunction in pathological gamblers: increased prolactin response to oral m-CPP versus placebo. CNS Spectr. 2006;11(12):956-64.
15. Quednow BB, Kuhn KU, Hoppe C, Westheide J, Maier W, Daum I, Wagner M. Elevated impulsivity and impaired decision-making cognition in heavy users of MDMA ("Ecstasy"). Psychopharmacology (Berl). 2007;189(4):517-30.
16. Steiger H, Joober R, Israel M, Young SN, Ng Ying Kin NM, Gauvin L, Bruce KR, Joncas J, Torkaman-Zehi A. The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes. Int J Eat Disord. 2005;37(1):57-60.
17. Blum K, Cull J, Braverman E, Comings D. Reward deficiency syndrome. Am Scientist. 1996;84:132-45.
18. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science. 1997;278(5335):58-62.
19. Goldman-Rakic PS. The prefrontal landscape: implications of frontal architecture for understanding human mentation and the central executive. In: Roberts A, Robbins T, Weiskrantz L, editors. The prefrontal cortex: executive and cognitive functions. Oxford: Oxford University Press; 1998. p. 87-102.
20. Breiter H, Gollub R, Weisskopf R, Kennedy DN, Makris N, Burke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE. Acute effects of cocaine on human brain activity and emotion. Neuron. 1997;19(3):591-611.
21. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, Kukes TJ, Renshaw PF. Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry. 1998;155(1):124-6.
22. Volkow ND, Wang GJ, Fischman MW, Foltin RW, Fowler JS, Abumrad NN, Vitkun S, Logan J, Gatley SJ, Pappas N, Hitzemann R, Shea CE. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature. 1997;386(6627):827-30.
23. Potenza MN, Steinberg MA, Skudlarski P, Fulbright RK, Lacadie CM, Wilber MK, Rounsaville BJ, Gore JC, Wexler BE. Gambling urges in pathological gambling: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2003;60(8):828-36.
24. Meyer G, Schwertfeger J, Exton MS, Janssen OE, Knapp W, Stadler MA, Schedlowski M, Kruger TH. Neuroendocrine response to casino gambling in problem gamblers. Psychoneuroendocrinology. 2004;29(10):1272-80.
25. Shinohara K, Yanagisawa A, Kagota Y, Gomi A, Nemoto K, Moriya E, Furusawa E, Furuya K, Terasawa K. Physiological changes in Pachinko players; beta-endorphin, catecholamines, immune system substances and heart rate. Appl Human Sci. 1999;18(2):37-42.
26. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychologic Med. 1997;27(2):473-5.
27. Weintraub D, Potenza MN. Impulse control disorders in Parkinson's disease. Curr Neurol Neurosci Rep. 2006;6(4):302-6.
28. Voon V, Hassan K, Zurowski M, Duff-Canning, de Souza M, Fox S, Lang AE, Miyasaki J. Prospective prevalence of pathologic gambling and medication association in Parkinson disease. Neurology. 2006;66(11):1750-2.
29. Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB. Association of dopamine agonist use with impulse control disorders in Parkinson's disease. Arch Neurol. 2006;63(7):969-73.
30. Klos KJ, Bower JH, Josephs KA, Matsumoto JY, Ahlskog JE. Pathological hypersexuality predominantly linked to adjuvant dopamine agonist therapy in Parkinson's disease and multiple system atrophy. Parkinsonism Relat Disord. 2005;11(6):381-6.
31. Caspi A, McClay J, Moffitt TE, Mill J, Martin J, Craig IW, Taylor A, Poulton R. Role of genotype in the cycle of violence in maltreated children. Science. 2002;297(5582):851-4.
32. Scherrer JF, Xian H, Kapp JM, Waterman B, Shah KR, Volberg R, Eisen SA. Association between exposure to childhood and lifetime traumatic events and lifetime pathological gambling in a twin cohort. J Nerv Mental Dis. 2007;195(1):72-8.
33. Schmitt LH, Harrison GA, Spargo RM. Variation in epinephrine and cortisol excretion rates associated with behavior in an Australian Aboriginal community. Am J Phys Anthropol. 1998;106(2):249-53.
34. Meyer G, Hauffa BP, Schedlowski M, Pawlak C, Stadler MA, Exton MS. Casino gambling increases heart rate and salivary cortisol in regular gamblers. Biol Psychiatry. 2000;48(9):948-53.
35. Krueger TH, Schedlowski M, Meyer G. Cortisol and heart rate measures during casino gambling in relation to impulsivity. Neuropsychobiology. 2005;52(4):206-11.
36. Potenza MN, Leung HC, Blumberg HP, Peterson BS, Fulbright RK, Lacadie CM, Skudlarski P, Gore JC. An FMRI stroop study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry. 2003;160(11):1990-4.
37. Saxena S, Rauch SL. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatr Clin North Amer. 2000;23(3):563-86.
38. Potenza MN. Should addictive disorders include non-substance-related conditions? Addiction. 2006;101(Suppl 1):142-51.
39. Reuter J, Raedler T, Rose M, Hand I, Glascher J, Buchel C. Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci. 2005;8(2):147-8.
40. Crockford DN, Goodyear B, Edwards J, Quickfall J, el-Guebaly N. Cue-induced brain activity in pathological gamblers. Biol Psychiatry. 2005;58(10):787-95.
41. Hollander E, Pallanti S, Baldini Rossi N, Sood E, Baker BR, Buchsbaum MS. Imaging monetary reward in pathological gamblers. World J Biol Psychiatry. 2005;6(2):113-20.
42. Eisen SA, Lin N, Lyons MJ, Scherrer JF, Griffith K, True WR, Goldberg J, Tsuang MT. Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction. 1998;93(9):1375-84.
43. Shah KR, Eisen SA, Xian H, Potenza MN. Genetic studies of pathological gambling: a review of methodology and analyses of data from the Vietnam era twin registry. J Gambling Studies. 2005;21(2):179-203.
44. Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, Chiu C, Dietz G, Gade R. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics. 1996;6(3):223-34.
45. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, Saucier G, Ferry L, Rosenthal RJ, Lesieur HR, Rugle LJ, MacMurray P. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry. 1997;2(1):44-56.
46. Comings DE, Gonzalez N, Wu S, Gade R, Muhleman D, Saucier G, Johnson P, Verde R, Rosenthal RJ, Lesieur HR, Rugle LJ, Miller WB, MacMurray JP. Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am J Med Genet. 1999;88(4):358-68.
47. Perez de Castro I, Ibanez A, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor. Pharmacogenetics. 1997;7(5):345-48.
48. Ibanez A, Blanco C, de Castro I, Fernandez-Piqueras J, Saiz-Ruiz J. Genetics of pathological gambling. J Gambling Studies. 2003;19(1):11-22.
49. Perez de Castro I, Ibanez A, Saiz-Ruiz J, Fernandez-Piqueras J. Genetic contribution to pathological gambling: association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected males. Pharmacogenetics. 1999;9(3):397-400.